#EPeeps, stay ahead in AF care with expert insights on EPLD’s AF Topic Center! More Evidence That Apixaban Causes Less Bleeding Than Rivaroxaban: The COBRRA trial found nearly twice the rate of clinically relevant bleeding with rivaroxaban vs apixaban. 📖hubs.ly/Q04vpysJ0